BG99110A - Анти-тахикининови трицикло-съединения,получаването им и фармацевтични композиции на тяхна основа - Google Patents

Анти-тахикининови трицикло-съединения,получаването им и фармацевтични композиции на тяхна основа Download PDF

Info

Publication number
BG99110A
BG99110A BG99110A BG9911094A BG99110A BG 99110 A BG99110 A BG 99110A BG 99110 A BG99110 A BG 99110A BG 9911094 A BG9911094 A BG 9911094A BG 99110 A BG99110 A BG 99110A
Authority
BG
Bulgaria
Prior art keywords
compounds
general formula
substituents
group
nhco
Prior art date
Application number
BG99110A
Other languages
Bulgarian (bg)
English (en)
Inventor
Vincenzo Pavone
Angelina Lombardi
Carlo Pedone
Carlo Maggi
Laura Quartara
Original Assignee
Laboratori Guidotti S.P.A.
A. Menarini Industrie Farmaceutiche Riunite S.R.L.
Malesci-Instituto Farmacobiologico S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Guidotti S.P.A., A. Menarini Industrie Farmaceutiche Riunite S.R.L., Malesci-Instituto Farmacobiologico S.P.A. filed Critical Laboratori Guidotti S.P.A.
Publication of BG99110A publication Critical patent/BG99110A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/22Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG99110A 1992-04-15 1994-10-14 Анти-тахикининови трицикло-съединения,получаването им и фармацевтични композиции на тяхна основа BG99110A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI920089A IT1262902B (it) 1992-04-15 1992-04-15 Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.
PCT/EP1993/000893 WO1993021227A1 (en) 1992-04-15 1993-04-13 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds

Publications (1)

Publication Number Publication Date
BG99110A true BG99110A (bg) 1995-09-29

Family

ID=11350056

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99110A BG99110A (bg) 1992-04-15 1994-10-14 Анти-тахикининови трицикло-съединения,получаването им и фармацевтични композиции на тяхна основа

Country Status (28)

Country Link
EP (1) EP0636146B1 (enExample)
JP (1) JPH08500331A (enExample)
KR (1) KR950700935A (enExample)
CN (1) CN1039126C (enExample)
AT (1) ATE156135T1 (enExample)
AU (1) AU671118B2 (enExample)
BG (1) BG99110A (enExample)
BR (1) BR9306248A (enExample)
CA (1) CA2118253A1 (enExample)
CZ (1) CZ254294A3 (enExample)
DE (1) DE69312698T2 (enExample)
DK (1) DK0636146T3 (enExample)
ES (1) ES2105265T3 (enExample)
FI (1) FI944838A7 (enExample)
GR (1) GR3024348T3 (enExample)
HR (1) HRP930814A2 (enExample)
HU (1) HUT70189A (enExample)
IL (1) IL105381A (enExample)
IT (1) IT1262902B (enExample)
MX (1) MX9302161A (enExample)
NO (1) NO943861L (enExample)
NZ (1) NZ251969A (enExample)
RO (1) RO112872B1 (enExample)
RU (1) RU94045890A (enExample)
SK (1) SK124294A3 (enExample)
TW (1) TW234718B (enExample)
WO (1) WO1993021227A1 (enExample)
ZA (1) ZA932644B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1283171B1 (it) * 1996-03-01 1998-04-16 Interdipartimentale Di Ricerca Composti solubili antagonisti delle tachichinine loro preparazione e loro uso in composizioni farmaceutiche
IT1291776B1 (it) 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1307809B1 (it) 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
DE3915361A1 (de) * 1989-05-11 1990-11-15 Merck Patent Gmbh Cyclopeptide

Also Published As

Publication number Publication date
ITFI920089A0 (it) 1992-04-15
AU671118B2 (en) 1996-08-15
SK124294A3 (en) 1995-07-11
ES2105265T3 (es) 1997-10-16
WO1993021227A1 (en) 1993-10-28
CN1080916A (zh) 1994-01-19
TW234718B (enExample) 1994-11-21
FI944838L (fi) 1994-10-14
GR3024348T3 (en) 1997-11-28
MX9302161A (es) 1994-05-31
RU94045890A (ru) 1996-09-10
RO112872B1 (ro) 1998-01-30
CZ254294A3 (en) 1995-07-12
IT1262902B (it) 1996-07-22
DE69312698T2 (de) 1997-12-04
AU4039593A (en) 1993-11-18
ZA932644B (en) 1993-10-22
NO943861D0 (no) 1994-10-13
CN1039126C (zh) 1998-07-15
HU9402977D0 (en) 1995-02-28
NZ251969A (en) 1997-12-19
IL105381A (en) 1998-02-22
HUT70189A (en) 1995-09-28
FI944838A0 (fi) 1994-10-14
DK0636146T3 (da) 1998-02-23
EP0636146B1 (en) 1997-07-30
DE69312698D1 (de) 1997-09-04
EP0636146A1 (en) 1995-02-01
ATE156135T1 (de) 1997-08-15
FI944838A7 (fi) 1994-10-14
ITFI920089A1 (it) 1993-10-15
KR950700935A (ko) 1995-02-20
JPH08500331A (ja) 1996-01-16
HRP930814A2 (en) 1996-12-31
NO943861L (no) 1994-10-13
CA2118253A1 (en) 1993-10-28
BR9306248A (pt) 1998-06-23

Similar Documents

Publication Publication Date Title
AU759442B2 (en) Novel LHRH antagonists with improved solubility characteristics
US5731285A (en) Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
JP3568952B2 (ja) 5位及び6位に修飾アミノアシル残基を有するlhrh拮抗薬
US5620959A (en) Bombesin antagonists
US5786335A (en) Sulfhydryl containing peptides for treating vascular disease
BG99110A (bg) Анти-тахикининови трицикло-съединения,получаването им и фармацевтични композиции на тяхна основа
KR100460165B1 (ko) 효과가향상된신규한lh-rh길항제
SK281899B6 (sk) Bicyklické peptidy, farmaceutický prostriedok s ich obsahom a ich použitie
TWI858016B (zh) 血球凝集素結合肽
HUT63178A (en) Process for producing bombesin antagonist polypeptides
CA2405724C (en) Substance p analogs for the treatment of cancer
JP2010150253A (ja) 肝癌を治療するための薬剤
US6596692B1 (en) Substance P analogs for the treatment of cancer
US5786447A (en) Opioid peptide analogs
EP0606222A1 (en) Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof
WO1992002546A1 (en) Synthetic peptides that antagonize neurokinin a, their salts and their manufacturing processes
EP1668027B1 (en) Cyclic peptides acting as urotensin-ii antagonists